ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

Registration

Thank you for attending ISALXVI 2017. To facilitate the planning of your stay, please find below all necessary information regarding registration and payment options.

 

REGISTRATION TYPES:

Registration all days (Feb 19-22, 2017)
"Early" registration fee: € 195
Registration and Payment before December 31, 2016
"Advance" registration fee: € 220
Registration and Payment: after January 1, 2017, but before February 17, 2017
On-site registration fee: € 280
Registration after February 17, 2017 or on-site

Registration day ticket: € 100
Sunday, Feb 19, 2017 to Tuesday, Feb 21, 2017

Registration half-day ticket: € 80
Wednesday, Feb 22, 2017

(The registration includes admission to all scientific sessions, the reception on Sunday evening, February 19, 2017, and the Abstract Booklet)

 

PAYMENT OPTIONS:

There are the following options to pay your registration fee either as advance payment or on-site payment.

Advance payment:
Advance payment can be made by check, money order or bank transfer to the ISALXVI account:
Account Holder: Verein für Leukämieforschung e.V.
Bank: Sparkasse Münsterland Ost,
IBAN: DE 64400 501 5000 1900 2468
BIC-Code: WELADED1MST

Please provide following additional details: Name of the registered participant plus Key word: ACUTE LEUKEMIAS XVI - 2017

On-site payment:
On-Site payment can only be made cash or by check. Please note that on-site payment by credit card is not possible!

 

SPECIAL TERMS:

FREE ACCESS TO ALL SESSIONS:

  • Invited Speakers and Faculty (As part of the official program, a registration is not required)
  • Members of the Scientific Committees
  • Participating Members of the AMLCG Study Group
  • Members of the LMU and TUM Munich
  • Members of the HelmholtzZentrum Munich
  • Members of the TZM Project Group "Akute Leukämie, MDS und MPS"
  • Former Members of the SFB 684 Munich
  • Students and Nurses (confirmation required)
  • Invited Representatives of the Participating Corporate Partners (confirmation required)